ACUTE ONSET OF SEVERE AUTOIMMUNE HEMOLYTIC-ANEMIA AFTER TREATMENT WITH 2-CHLORODEOXYADENOSINE FOR CHRONIC LYMPHOCYTIC-LEUKEMIA

被引:20
作者
FLEISCHMAN, RA [1 ]
CROY, D [1 ]
机构
[1] VET ADM MED CTR,LEXINGTON,KY
关键词
D O I
10.1002/ajh.2830480423
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:293 / 293
页数:1
相关论文
共 5 条
[1]  
BASTION Y, 1992, ANN ONCOL, V3, P171
[2]   PURINE METABOLISM OF LYMPHOCYTES - TARGETS FOR CHEMOTHERAPY DRUG DEVELOPMENT [J].
CARRERA, CJ ;
SAVEN, A ;
PIRO, LD .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1994, 8 (02) :357-381
[3]  
DIRAIMONDO F, 1993, LEUKEMIA LYMPHOMA, V11, P63
[4]   RESPONSE TO 2-CHLORODEOXYADENOSINE IN PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA RESISTANT TO FLUDARABINE [J].
JULIUSSON, G ;
ELMHORNROSENBORG, A ;
LILIEMARK, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (15) :1056-1061
[5]   SEVERE AUTOIMMUNE HEMOLYTIC-ANEMIA IN A PATIENT WITH CHRONIC LYMPHOCYTIC-LEUKEMIA RESPONSIVE TO FLUDARABINE-BASED TREATMENT [J].
TOSTI, S ;
CARUSO, R ;
DADAMO, F ;
PICARDI, A ;
EGE, MA ;
GIRELLI, G ;
MAURO, FR ;
MAURILLO, L ;
AMADORI, S .
ANNALS OF HEMATOLOGY, 1992, 65 (05) :238-239